Many studies have evaluated various prognostic markers for canine melanocytic neoplasms
either as primary or secondary goals; however, design, methodology, and statistical …

Canine osteosarcoma (OS) is an aggressive tumour that accounts for approximately 90% of
primary bone tumours in the dog. Although the standard treatments (including limb …

Background We have previously demonstrated that both canine and human OSA cell lines,
as well as 8 fresh canine OSA tumor samples, exhibit constitutive phosphorylation of STAT3 …

Background We hypothesized that the addition of toceranib to metronomic
cyclophosphamide/piroxicam therapy would significantly improve disease-free interval (DFI) …

Melanoma is a relatively common tumor of dogs, especially in those with significant levels of
skin pigmentation. Melanomas in cats are relatively rare. Melanoma arises from …

Canine oral fibrosarcoma (oFSA) is a malignant, infiltrating, mesenchymal tumour affecting
the oral cavity primarily of medium to large middle aged dogs. The diagnosis often is made …

Simple Summary Mast cell tumor (MCT) is the most common malignant skin tumor in dogs.
In order to gain more information on the prognostic markers of MCT, the role of the …

The similarities between human and canine osteosarcoma with regard to histology,
biological behavior and molecular genetic alterations suggest that the dog provides a …

Canine cutaneous mast cell tumour (CMCT) is a common cutaneous tumour in dog, with a
higher incidence than in human. CMCT is classified in three subgroups, well and …

This retrospective study evaluated the outcomes of dogs with macroscopic pulmonary
metastasis of appendicular osteosarcoma (OSA) treated with toceranib. Medical records of …